Farsighted? These Eye Drops Could Eventually Replace Your Reading Glasses

If you have not tested it yourself, you certainly saw the older family members start to keep smartphones and restaurants until their noses, and they deviate in the small text. This is because with our age, we all develop the sheikhs, or the age-related play-with a focus on the near things or text. This is where surgery or reading glasses usually come, but new research indicates that there may be another option.

The researchers have proven that after taking special drops in the eye two or three times a day, most participants in a retroactive effect can read two or more additional lines on the Jaeger chart, an eye scheme used for testing near visual intensity. Giovana Pinozi, Director of the Seven Research Center in Buenos Aires, presented the research on Sunday, September 14th, at the conference 43 of the European Association for Capricorn and Refraction surgery (ESCRS).

Surgery is not for everyone

“We have conducted this research due to the unparalleled medical needs in the Britisopia administration,” Pinzzi said in Escrs. “There is a group of patients who have limited options alongside glasses, who are not candidates for surgery; these are the focus of our primary attention. We sought to provide strong clinical guides that support an innovative drug solution to provide patients with an unpleasant, effective and effective alternative.”

Precipopia seems to be family work. Pinozi’s father, the late Jorge Pinozi, was a researcher at the center of his daughter himself, who developed eye drops. The formula contains two active-alternative components, which restricts students and corresponds to the ciliary muscles (the muscles involved in the eye’s ability to see things at different distances), and Diclofenac, often diclofenac due to the anti-inflammatory drug.

766 patients (373 women, 393 men, an average age of 55) took the eye declines twice a day, with the possibility of a third administration when needed. While everyone received eye drops at the same dose of diclofenac, the focus of bilocarin was either 1 %, 2 % or 3 %. The researchers tested patients with the Jaeger scheme an hour after the first administration and then continued to monitor them for two years.

“Our most important results showed rapid and sustainable improvements in the near vision of all three concentrations. One hour after obtaining the first drops, patients had an average improved 3.45 Jayger lines. The treatment also improved the focus in all distances,” Pinozi said to congress, as observed in the statement. “Impressive, 99 % of 148 patients in the Bilocarbin Group by 1 % to the optimal vision and managed to read two or more lines. About 83 % of all patients kept a good functional vision in 12 months.”

69 % of 248 patients who took 2 % formulation and 84 % of 370 patients who eat 3 % format can read three or more additional lines on the Jaeger chart. The improvements that were seen in the experiment lasted for up to two years, and benozzi had patients outside the study who took the eye declines for more than a decade.

More necessary research

Pilocarpine can usually cause, among other side effects, lack of visibility, dim vision or dark, vision of flashes of light or “buoys”, and in some rare cases, separate retina. Some of the harmful side effects that patients suffer in the recent study include a temporary, temporary vision, irritation during eye management and headache, but no one has stopped treatment.

“Almost all patients have experienced positive vision improvements, although the improvement of the improvement depends on their vision before treatment in the first place,” Penosi explained. “Patients with less severe housing responded to better concentrations to 1 %, while those with more advanced prior needed need to be 2 % or 3 % higher concentrations to achieve significant visual improvement.”

Benozzi has argued that eye drops are a suitable alternative to dealing with forced representation that can reduce patients’ need for reading glasses, although they are not intended to replace surgery. “Eye Care Specialists now have a guarantee on evidence that expands the spectrum care for the glasses and surgery.”

While the study is impressive for its large number of patients who followed over an important period, it is limited by being a unilateral study retroactively-in the sense that all patients were treated in the same center and their data was collected after the truth.

“The study retroactively by Dr. Pinozi indicates that eye drops containing bilocarin and Diclofenac are close to up to two years, but the limited design means that the results may not apply to everyone,” said Burkard Dick, head of the ophthalmology department at university ophthalmology in Germany. “The use of bilocarin in a long term may cause side effects … broader and long -term studies are needed to confirm safety and effectiveness before recommending this treatment widely.”

Even with these restrictions, the results indicate a future where a simple eye drop can help delay the need for reading glasses.